Dysplasia detection in Barrett's esophagus: Is the glass half full or half empty?

Endoscopic surveillance is currently recommended in patients with Barrett's esophagus (BE) to detect prevalent and incident dysplasia/esophageal adenocarcinoma. This strategy is underpinned by the concepts that (1) dysplasia can be treated endoscopically to prevent early gastric cancer (EAC),1 and (2) early-stage EAC (without symptomatic dysphagia and muscularis propria invasion) can be successfully treated (endoscopically) with excellent long-term survival.2

Source: Gastrointestinal Endoscopy - October 19, 2019 Category: Gastroenterology Authors: Prasad G. Iyer Tags: Original article Source Type: research